Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for anxiety in children with cancer
IRCT20190804044429N13Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olanzapine in lymphoid leukemia and anxiety disorder, sponsored by Mazandaran University of Medical Sciences. Started Sep 2024; status: completed.
02
Drugs
olanzapine
03
Conditions
lymphoid leukemiaanxiety disorder
Beyond the preview
Go deeper on IRCT20190804044429N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N13.